Skip to main content
. 2021 Feb 17;6(5):1416–1422. doi: 10.1016/j.ekir.2021.02.013

Figure 2.

Figure 2

Incidence of acute kidney injury (AKI) among patients treated with chimeric antigen receptor T-cell (CAR-T) therapies. CI, confidence interval.